Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Coactinon emivirine (MKC-442): Update

Triangle Pharmaceuticals Inc. (VIRS), Durham, N.C.
Product: Coactinon emivirine (MKC-442)
Business: Infectious

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE